References
Bearder, A., K. Bearder, M. Brzica, S. Brzica, R. Hagelstrom, G. Hagelstrom, W. K. Halvorson III, et al. v. State of Minnesota, Minnesota Department of Health. 2009. Hennepin County Civil Court, Fourth Judicial District, State of Minnesota.
Beleno, A., G. N. Courtney, M. Overath, K. A. Taylor, and N. Pacheco v. Texas Department of State Health Services, D. L. Lakey, Texas A&M University, N. W. Dickey, and R. E. McCallum. 2009. Texas Western District Court.
Burse, V. W., M. R. DeGuzman, M. P. Korver, A. R. Najam, C. C. Williams, W. H. Hannon, and B. L. Therrell. 1997. Preliminary investigation of the use of dried-blood spots for the assessment of in utero exposure to environmental pollutants. Biochemistry and Molecular Medicine 61(2):236–239.
CDC (Centers for Disease Control and Prevention). 2008. Impact of expanded newborn screening—United States, 2006. Morbidity and Mortality Weekly Report 57(37): 1012–1015.
Comeau, A. 2010. Continuum from service to research. Presented at the Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research: A Workshop, Washington, DC.
Gwinn, M., M. Pappaioanou, J. R. George, W. H. Hannon, S. C. Wasser, M. A. Redus, R. Hoff, G. F. Grady, A. Willoughby, A. C. Novello, et al. 1991. Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA 265(13):1704–1708.
Harmon, A. 2010. Where’d you go with my DNA? New York Times, April 23, WK1.
Henderson, L. O., M. K. Powell, W. H. Hannon, J. T. Bernert, Jr., K. A. Pass, P. Fernhoff, C. D. Ferre, L. Martin, E. Franko, R. W. Rochat, M. D. Brantley, and E. Sampson. 1997. An evaluation of the use of dried blood spots from newborn screening for monitoring the prevalence of cocaine use among childbearing women. Biochemistry and Molecular Medicine 61(2):143–151.
Hoff, R., V. P. Berardi, B. J. Weiblen, L. Mahoney-Trout, M. L. Mitchell, and G. F. Grady. 1988. Seroprevalence of human immunodeficiency virus among childbearing women. Estimation by testing samples of blood from newborns. New England Journal of Medicine 318(9):525–530.
Sahai, I., and D. Marsden. 2009. Newborn screening. Critical Reviews in Clinical Laboratory Sciences 46(2):55–82.
Skloot, R. 2010. The Immortal Life of Henrietta Lacks. New York: Crown.
Spliethoff, H. M., L. Tao, S. M. Shaver, K. M. Aldous, K. A. Pass, K. Kannan, and G. A. Eadon. 2008. Use of newborn screening program blood spots for exposure assessment: Declining levels of perfluorinated compounds in New York State infants. Environmental Science and Technology 42(14):5361–5367.
Therrell, B. L., W. H. Hannon, K. A. Pass, F. Lorey, C. Brokopp, J. Eckman, M. Glass. R. Heidenreich, S. Kinney, S. Kling, G. Landenburger, F. J. Meaney, E. R. B. McCabe, S. Panny, M. Schwartz, and E. Shapira. 1996. Guidelines for the retention, storage, and use of residual dried blood spot samples after newborn screening analysis: Statement of the Council of Regional Networks for Genetic Services. Biochemistry and Molecular Medicine 57:116–124.
Wilcken, B., and V. Wiley. 2008. Newborn screening. Pathology 40(2):104–115.
Yarborough, M., K. Fryer-Edwards, G. Geller, and R. R. Sharp. 2009. Transforming the culture of biomedical research from compliance to trustworthiness: Insights from nonmedical sectors. Academic Medicine 84(4):472–477.
